Autopsy report · NCT04631705

SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

“Change in viral variant epidemiology”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 9 months before it stopped.
• 45 participants enrolled.
• Results were posted on the registry 3 years after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1, Phase 2

Sponsor

University of Cologne

Sponsor type

University, hospital or other

Conditions

SARS-CoV-2 Infection

Interventions

DZIF-10c; DZIF-10c; Placebo; Placebo

Participants

45

Sites

6

Countries

Germany

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.